Actively Recruiting
PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc
Led by British Columbia Cancer Agency · Updated on 2025-09-25
30
Participants Needed
1
Research Sites
356 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This pilot clinical trial aims to assess the real world quality of life and survival of patients treated with targeted therapy that has preliminary evidence of efficacy in subjects with advanced rare cancers or cancer harbouring rare molecular aberrations. The treatment has been granted conditional or full approved by Health Canada (HC) as effective and safe. Due to the rarity of the cancer or molecular aberration the uncertainty level of the health technology assessment (HTA) by the pan Canadian Oncology Review (pCODR) was too high for consideration of funding or it was not submitted for consideration. Consequently, the goal of this study is to generate real world evidence to support HTA decision making throughout the life cycle of the product.
CONDITIONS
Official Title
PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older at the time of consent
- Diagnosed with an incurable malignancy with rare cancer type or rare molecular aberration
- Currently receiving Health Canada approved targeted therapy not nationally funded
- ECOG performance status of 0 to 2
- Life expectancy of at least 12 weeks
- Adequate blood and organ function for drug treatment as assessed by clinician
- Asymptomatic or treated brain metastases allowed
- Ability to give informed consent for study procedures
You will not qualify if you...
- Treatment with any approved or investigational agent or participation in another therapeutic clinical trial within 14 days before enrollment
- Unable to complete quality of life questionnaires
- Considered unfit by treating clinician to participate in this protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
BC Cancer
Vancouver, British Columbia, Canada, V5Z4E6
Actively Recruiting
Research Team
S
Samantha Pollard, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here